{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:36:08Z","timestamp":1761676568409,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T00:00:00Z","timestamp":1510876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI13C0826","HI14C2664"],"award-info":[{"award-number":["HI13C0826","HI14C2664"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12272-017-0985-z","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T06:52:41Z","timestamp":1510901561000},"page":"219-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice"],"prefix":"10.1007","volume":"41","author":[{"given":"Ara","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seo Ri","family":"Wui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji In","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hien Thi Thu","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmoo","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Im","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Ki","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na Gyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"key":"985_CR1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(02)00772-7","volume":"21","author":"M Abe","year":"2003","unstructured":"Abe M, Kuzuhara S, Kino Y (2003) Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells. Vaccine 21:1989\u20131994","journal-title":"Vaccine"},{"key":"985_CR2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4049\/jimmunol.0803706","volume":"183","author":"TA Barr","year":"2009","unstructured":"Barr TA, Brown S, Mastroeni P, Gray D (2009) B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c. J Immunol 183:1005\u20131012","journal-title":"J Immunol"},{"key":"985_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","volume":"8","author":"DWC Beasley","year":"2008","unstructured":"Beasley DWC, Lewthwaite P, Solomon T (2008) Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther 8:95\u2013106","journal-title":"Expert Opin Biol Ther"},{"key":"985_CR4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","volume":"89","author":"GL Campbell","year":"2011","unstructured":"Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS (2011) Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 89:766\u2013774","journal-title":"Bull World Health Organ"},{"key":"985_CR5","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1099\/vir.0.067280-0","volume":"95","author":"HW Chen","year":"2014","unstructured":"Chen HW, Huang HW, Hu HM, Chung HH, Wu SH, Chong P, Tao MH, Pan CH (2014) A poorly neutralizing IgG2a\/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus. J Gen Virol 95:1983\u20131990","journal-title":"J Gen Virol"},{"key":"985_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcma.2014.12.009","volume":"78","author":"HL Chen","year":"2015","unstructured":"Chen HL, Chang JK, Tang RB (2015) Current recommendations for the Japanese encephalitis vaccine. J Chin Med Assoc 78:271\u2013275","journal-title":"J Chin Med Assoc"},{"key":"985_CR7","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1016\/j.vaccine.2006.04.048","volume":"24","author":"YJ Cho","year":"2006","unstructured":"Cho YJ, Ahn BY, Lee NG, Lee DH, Kim DS (2006) A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy. Vaccine 24:5862\u20135871","journal-title":"Vaccine"},{"key":"985_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","volume":"3","author":"A Pasquale Di","year":"2015","unstructured":"Di Pasquale A, Preiss S, Da Silva FT, Garcon N (2015) Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines 3:320\u2013343","journal-title":"Vaccines"},{"key":"985_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1501.080311","volume":"15","author":"TE Erlanger","year":"2009","unstructured":"Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K (2009) Past, present, and future of Japanese encephalitis. Emerg Infect Dis 15:1\u20137","journal-title":"Emerg Infect Dis"},{"key":"985_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","volume":"10","author":"SB Halstead","year":"2011","unstructured":"Halstead SB, Thomas SJ (2011) New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev Vaccines 10:355\u2013364","journal-title":"Expert Rev Vaccines"},{"key":"985_CR11","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1016\/j.vaccine.2012.04.079","volume":"30","author":"JE Han","year":"2012","unstructured":"Han JE, Wui SR, Park SA, Lee NG, Kim KS, Cho YJ, Kim HJ, Kim HJ (2012) Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix\u2122 in mice. Vaccine 30:4127\u20134134","journal-title":"Vaccine"},{"key":"985_CR12","doi-asserted-by":"crossref","first-page":"e85838","DOI":"10.1371\/journal.pone.0085838","volume":"9","author":"JE Han","year":"2014","unstructured":"Han JE, Wui SR, Kim KS, Cho YJ, Cho WJ, Lee NG (2014) Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-O-acylated lipooligosaccharide. PLoS ONE 9:e85838","journal-title":"PLoS ONE"},{"key":"985_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2014.08.024","volume":"475","author":"SY Kim","year":"2014","unstructured":"Kim SY, Lee SJ, Lim SJ (2014) Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer. Int J Pharmaceut 475:49\u201359","journal-title":"Int J Pharmaceut"},{"key":"985_CR14","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","volume":"141","author":"J Kimura-Kuroda","year":"1988","unstructured":"Kimura-Kuroda J, Yasui K (1988) Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 141:3606\u20133610","journal-title":"J Immunol"},{"key":"985_CR15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2567.2007.02560.x","volume":"121","author":"KS Korsholm","year":"2007","unstructured":"Korsholm KS, Agger EM, Foged C, Christensen D, Dietrich J, Andersen CS, Geisler C, Andersen P (2007) The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology 121:216\u2013226","journal-title":"Immunology"},{"key":"985_CR16","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/JVI.02611-10","volume":"85","author":"M Larena","year":"2011","unstructured":"Larena M, Regner M, Lee E, Lobigs M (2011) Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis. J Virol 85:5446\u20135455","journal-title":"J Virol"},{"key":"985_CR17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/eji.201243152","volume":"43","author":"M Larena","year":"2013","unstructured":"Larena M, Regner M, Lobigs M (2013) Cytolytic effector pathways and IFN-gamma help protect against Japanese encephalitis. Eur J Immunol 43:1789\u20131798","journal-title":"Eur J Immunol"},{"key":"985_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abio.1998.2961","volume":"267","author":"CH Lee","year":"1999","unstructured":"Lee CH, Tsai CM (1999) Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal Biochem 267:161\u2013168","journal-title":"Anal Biochem"},{"key":"985_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","volume":"82","author":"EB Lindblad","year":"2004","unstructured":"Lindblad EB (2004) Aluminium compounds for use in vaccines. Immunol Cell Biol 82:497\u2013505","journal-title":"Immunol Cell Biol"},{"key":"985_CR20","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","volume":"25","author":"A Lyons","year":"2007","unstructured":"Lyons A, Kanesa-Thasan N, Kuschner RA, Eckels KH, Putnak R, Sun W, Burge R, Towle AC, Wilson P, Tauber E, Vaughn DW (2007) A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine 25:3445\u20133453","journal-title":"Vaccine"},{"key":"985_CR21","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.vaccine.2004.08.048","volume":"23","author":"GL Morefield","year":"2005","unstructured":"Morefield GL, Jiang D, Romero-Mendez IZ, Geahlen RL, Hogenesch H, Hem SL (2005) Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine 23:1502\u20131506","journal-title":"Vaccine"},{"key":"985_CR22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/14760584.2013.811185","volume":"12","author":"A Mount","year":"2013","unstructured":"Mount A, Koernig S, Silva A, Drane D, Maraskovsky E, Morelli AB (2013) Combination of adjuvants: the future of vaccine design. Expert Rev Vaccines 12:733\u2013746","journal-title":"Expert Rev Vaccines"},{"key":"985_CR23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CDLI.8.6.1115-1119.2001","volume":"8","author":"S Romero-Steiner","year":"2001","unstructured":"Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM (2001) Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immun 8:1115\u20131119","journal-title":"Clin Diagn Lab Immun"},{"key":"985_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3713656","author":"JI Ryu","year":"2016","unstructured":"Ryu JI, Park SA, Wui SR, Ko A, Han JE, Choi JA, Song MK, Kim KS, Cho YJ, Lee NG (2016) A de-O-acylated lipooligosaccharide-based adjuvant system promotes antibody and Th1-type immune responses to H1N1 pandemic influenza vaccine in mice. Biomed Res Int. https:\/\/doi.org\/10.1155\/2016\/3713656","journal-title":"Biomed Res Int"},{"key":"985_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4014\/jmb.1706.06009","volume":"27","author":"JI Ryu","year":"2017","unstructured":"Ryu JI, Wui SR, Ko A, Lee YJ, Do H, Kim HJ, Rhee IM, Park SA, Kim KS, Cho YJ, Lee NG (2017) Increased immunogenicity and protective efficacy of a P. aeruginosa vaccine in mice using an alum and de-O-acylated lipooligosaccharide adjuvant system. J Microbiol Biotechnol 27:1539\u20131548","journal-title":"J Microbiol Biotechnol"},{"key":"985_CR26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/0264-410X(93)90127-J","volume":"11","author":"DL Skea","year":"1993","unstructured":"Skea DL, Barber BH (1993) Adhesion-mediated enhancement of the adjuvant activity of alum. Vaccine 11:1018\u20131026","journal-title":"Vaccine"},{"key":"985_CR27","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","volume":"29","author":"Y Gessel Van","year":"2011","unstructured":"Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S (2011) Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO\u00ae) induced neutralizing antibody titers. Vaccine 29:5925\u20135931","journal-title":"Vaccine"},{"key":"985_CR28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/IJGM.S6281","volume":"2","author":"V Wiwanitkit","year":"2009","unstructured":"Wiwanitkit V (2009) Development of a vaccine to prevent Japanese encephalitis: a brief review. Int J Gen Med 2:195\u2013200","journal-title":"Int J Gen Med"},{"key":"985_CR29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.intimp.2011.03.020","volume":"11","author":"SR Wui","year":"2011","unstructured":"Wui SR, Kim HK, Han JE, Kim JM, Kim YH, Chun JH, Cho YJ, Lee NG (2011) A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice. Int Immunopharmacol 11:1195\u20131204","journal-title":"Int Immunopharmacol"},{"key":"985_CR30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12272-013-0034-5","volume":"36","author":"SR Wui","year":"2013","unstructured":"Wui SR, Han JE, Kim YH, Rhie GE, Lee NG (2013) Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine. Arch Pharm Res 36:464\u2013471","journal-title":"Arch Pharm Res"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-017-0985-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-017-0985-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-017-0985-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T17:23:14Z","timestamp":1693243394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-017-0985-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,17]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1007\/s12272-017-0985-z","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"type":"print","value":"0253-6269"},{"type":"electronic","value":"1976-3786"}],"subject":[],"published":{"date-parts":[[2017,11,17]]}}}